|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07D 413/06 | |
| C07D 413/14 | |||
| A61K 31/4245 | |||
| A61K 31/4523 | |||
| A61P 25/24 |
| (11) | Number of the document | 2590969 |
| (13) | Kind of document | T |
| (96) | European patent application number | 11729458.7 |
| Date of filing the European patent application | 2011-07-04 | |
| (97) | Date of publication of the European application | 2013-05-15 |
| (45) | Date of publication and mention of the grant of the patent | 2014-10-15 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/GB2011/051256 |
| Date | 2011-07-04 |
| (87) | Number | WO 2012/004588 |
| Date | 2012-01-12 |
| (30) | Number | Date | Country code |
| 361585 P | 2010-07-06 | US |
| (72) |
BÖKMAN-WINIWARTER, Susanne, Doris, Margit, SE
FREDENWALL, Marlene, SE
HOGNER, Anders, Carl, SE
JOHANSSON, Lars Anders, Mikael, SE
JUDKINS, Robert, Andrew, SE
LI, Lanna, GB
LÖFBERG, Björn, Christian, Ingvar, SE
VON UNGE, Per Oskar, Sverker, SE
|
| (73) |
AstraZeneca AB,
151 85 Södertälje,
SE
|
| (54) | Therapeutic agents 976 |
| Therapeutic agents 976 |